<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2794-1140</journal-id>
<journal-title><![CDATA[Pharmaceutical Care España]]></journal-title>
<abbrev-journal-title><![CDATA[Pharm Care Esp.]]></abbrev-journal-title>
<issn>2794-1140</issn>
<publisher>
<publisher-name><![CDATA[Fundación Pharmaceutical Care España]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2794-11402025000101001</article-id>
<article-id pub-id-type="doi">10.60103/phc.v27.e886</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación de la adherencia al tratamiento en pacientes tratados con acenocumarol en un programa de telecuidado]]></article-title>
<article-title xml:lang="en"><![CDATA[Assessment of treatment adherence in patients receiving acenocoumarol in a telecare program]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bertoldo]]></surname>
<given-names><![CDATA[Pamela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rinaldin]]></surname>
<given-names><![CDATA[Gina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Catube]]></surname>
<given-names><![CDATA[Perla Valeria]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Católica de Córdoba Facultad de Ciencias de la Salud ]]></institution>
<addr-line><![CDATA[Córdoba ]]></addr-line>
<country>Argentina</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Municipal Principe de Asturias  ]]></institution>
<addr-line><![CDATA[Córdoba ]]></addr-line>
<country>Argentina</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>27</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2794-11402025000101001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2794-11402025000101001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2794-11402025000101001&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Introducción: La adherencia al tratamiento con anticoagulantes orales es esencial para garantizar la eficacia y la seguridad de la terapia. Este estudio evalúa la adherencia terapéutica en pacientes tratados con acenocumarol utilizando el cuestionario Morisky-Green, la experiencia del paciente mediante el instrumento IEXPAC y la seguridad en el uso de este fármaco. Método: Se desarrolló un estudio en pacientes mayores de 18 años con enfermedad cardiovascular en tratamiento con acenocumarol, incluidos en un programa de entrega programada y seguimiento por telefarmacia. Consistió en una revisión retrospectiva de historias clínicas para evaluar la adherencia al tratamiento y las internaciones en 2023 y 2024 y en forma prospectiva, se realizaron entrevistas telefónicas estructuradas para evaluar tanto la adherencia y la satisfacción con la atención recibida, como el conocimiento del paciente sobre su enfermedad. Resultados: Se incluyeron 10 pacientes con prescripción de acenocumarol (7 varones y 3 mujeres con una edad promedio de 57 años, de un padrón de 179 pacientes. El 81 % retira la medicación trimestralmente y todos tienen controles de RIN; un paciente fue internado en 2024 por hematuria asociada al tratamiento. En cuanto a los resultados de las entrevistas telefónicas, el 87,5 % identificó a su cardiólogo y mostró adherencia, el 63,5 % no reconocía los signos de alarma del tratamiento, el 87,5 % expresó satisfacción con la atención recibida y solo el 70 % recibió información sobre dieta y fármacos. Este último aspecto evidencia la necesidad de fortalecer la educación sanitaria, motivo por el cual se organizó un taller dirigido a los pacientes y se elaboró un folleto educativo. Conclusiones: Se identificó alta adherencia, aunque falta información en relación con la seguridad del uso de anticoagulantes orales. La satisfacción con la atención fue alta.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Introduction: Adherence to treatment with oral anticoagulants is essential to ensure the effectiveness and safety of the therapy. This study evaluates therapeutic adherence in patients treated with acenocoumarol using the Morisky-Green questionnaire, the patient's experience with the IEXPAC instrument and the safety in the use of this drug. Method: A study was carried out with patients over 18 years of age with cardiovascular disease treated with acenocoumarol, included in a programmed delivery program and telepharmacy follow-up. A retrospective review of medical records was performed to evaluate adherence to treatment and hospitalizations in 2023 and 2024. Prospectively, structured telephone interviews were conducted to evaluate adherence and satisfaction with the care received. Results: Ten patients prescribed acenocoumarol were included (7 men and 3 women with a mean age of 57 years, from a registry of 179 patients). 81% discontinued the medication quarterly and all had INR controls; one patient was hospitalized in 2024 for treatment-associated hematuria. Regarding the results of the telephone interviews, 87.5% identified their cardiologist and showed adherence, 63.5% did not recognize the warning signs of treatment, 87.5% expressed satisfaction with the care received and only 70% received information on diet and medications. This last aspect highlights the need to strengthen health education, which is why a workshop for patients was organized and an educational brochure was developed. Conclusions: High adherence was identified although there is a lack of information on the safety of the use of oral anticoagulants. Satisfaction with care was high.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[telemedicina]]></kwd>
<kwd lng="es"><![CDATA[acenocumarol]]></kwd>
<kwd lng="es"><![CDATA[adherencia]]></kwd>
<kwd lng="es"><![CDATA[seguimiento farmacoterapéutico.]]></kwd>
<kwd lng="en"><![CDATA[telemedicine]]></kwd>
<kwd lng="en"><![CDATA[acenocumarol]]></kwd>
<kwd lng="en"><![CDATA[adherence]]></kwd>
<kwd lng="en"><![CDATA[pharmacotherapeutic monitoring.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacob]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Reynolds]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Chattopadhyay]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Hopkins]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Therrien]]></surname>
<given-names><![CDATA[NL]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Durthaler]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Rask]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cuellar]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Clymer]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Kottke]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
</person-group>
<collab>Community Preventive Services Task Force (CPSTF)</collab>
<article-title xml:lang=""><![CDATA[Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease]]></article-title>
<source><![CDATA[American journal of preventive medicine]]></source>
<year>2022</year>
<volume>62</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e202-22</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Kini]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Levy]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Ho]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication adherence in cardiovascular medicine]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2021</year>
<volume>374</volume>
<numero>1493</numero>
<issue>1493</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puigdemont]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<name>
<surname><![CDATA[Valverde-Merino]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adherencia terapéutica: factores modificadores y estrategias de mejora]]></article-title>
<source><![CDATA[Ars Pharm]]></source>
<year>2018</year>
<volume>59</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>251-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres Celi]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Solano Rubio]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percepción de la calidad de atención en servicios de salud del área de materno infantil]]></article-title>
<source><![CDATA[Cienc Lat Salud]]></source>
<year>2024</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>5678-96</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brandariz-Núñez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreiro-Gómez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Suanzes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Margusino-Framiñán]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[De la Cámara-Gómez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fandiño-Orgueira]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of adverse drug reactions associated with emergency department visits and risk factors for hospitalization]]></article-title>
<source><![CDATA[Farm Hosp]]></source>
<year>2023</year>
<volume>47</volume>
<page-range>20-5</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goienetxea]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seguimiento farmacoterapéutico: competencia del farmacéutico]]></article-title>
<source><![CDATA[Farm Comunitarios]]></source>
<year>2017</year>
<volume>9</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>14-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Roco]]></surname>
<given-names><![CDATA[Á]]></given-names>
</name>
<name>
<surname><![CDATA[Román]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rojo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nieto]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impacto de la atención farmacéutica en la calidad del tratamiento con acenocumarol en pacientes con fibrilación auricular]]></article-title>
<source><![CDATA[Rev Med Chil]]></source>
<year>2021</year>
<volume>149</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>724-32</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hussain]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bowen]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exploring Pharmacist Roles in Telepharmacy for Chronic Disease Management in New York State: A Qualitative Inquiry into Improving Implementation, Patient Communication, and Healthcare Technology Support]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2024</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pagès-Puigdemont]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Valverde-Merino]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Métodos para medir la adherencia terapéutica]]></article-title>
<source><![CDATA[Ars Pharm]]></source>
<year>2018</year>
<volume>59</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>163-72</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mira]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Nuño-Solinís]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Guilabert]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Solas]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Cano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[González-Mestre]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and validation of an instrument for assessing patient experience of chronic illness care]]></article-title>
<source><![CDATA[Int J Integr Care]]></source>
<year>2016</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iglesias]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[García Martín]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Casas Sepúlveda]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Martín Ballesteros]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Villarín Castro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cumplimiento terapéutico en pacientes en tratamiento con anticoagulantes orales en Atención Primaria]]></article-title>
<source><![CDATA[Rev Clin Med Fam]]></source>
<year>2021</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>12-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubio-Armendáriz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Alberto-Armas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Plasín-Rodríguez]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Padrón-Fuentes]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Casanova-Herrera]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
<name>
<surname><![CDATA[González-González]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acenocumarol: uso, adherencia y conocimiento del usuario. Oportunidades para la Atención Farmacéutica]]></article-title>
<source><![CDATA[JONNPR]]></source>
<year>2021</year>
<volume>6</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1427-45</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez de Morentin de Benito]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Treceño Lobato]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Valles Martín]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valoración de la incidencia de PRM/RNM en pacientes tratados con anticoagulantes orales y evaluación de la intervención farmacéutica en farmacia comunitaria]]></article-title>
<source><![CDATA[FarmaJournal]]></source>
<year>2023</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-47</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sáez-Benito]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Papel del farmacéutico en la atención al paciente en tratamiento con anticoagulantes orales]]></article-title>
<source><![CDATA[Pharm Care Esp]]></source>
<year>2022</year>
<volume>24</volume>
<numero>Supl 1</numero>
<issue>Supl 1</issue>
<page-range>43-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sáez-Benito]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Sáez-Benito]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Magallón]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Berenguer]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of the pharmacist in a patient's care for individuals undergoing anticoagulant therapy: a case report]]></article-title>
<source><![CDATA[Life (Basel)]]></source>
<year>2024</year>
<volume>14</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
